Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flora Peyvandi

Showing results (411-420 of 611) with videos related to

Pageof 62
Sort By:
Journal of Thrombosis and Haemostasis : JTH|August 22, 2024
Gene therapy for people with hemophilia B: a proposed care delivery model in ItalyGiancarlo Castaman, Giovanni Di Minno, Paolo Simioni, et al.
Research and Practice in Thrombosis and Haemostasis|June 3, 2026
Real-world provider experiences with hemophilia A gene therapy: administration of valoctocogene roxaparvovecFlora Peyvandi, Robert Klamroth, Johannes Oldenburg, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2025
Post hoc analysis of bleeding episodes and clinically relevant pharmacokinetic parameters among children <12 years old with severe hemophilia A receiving once-weekly efanesoctocog alfa prophylaxis in the XTEND-Kids phase 3 multinational trialLynn Malec, Mary Mathias, Amy L Dunn, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 19, 2022
Real-world data on emicizumab prophylaxis in the Milan cohortSara Arcudi, Roberta Gualtierotti, Sonia Marino, et al.
The American Journal of Gastroenterology|July 4, 2020
Acute Portal Vein Thrombosis in SARS-CoV-2 Infection: A Case ReportVincenzo La Mura, Andrea Artoni, Ida Martinelli, et al.
Blood|May 11, 2006
The thrombospondin-1 N700S polymorphism is associated with early myocardial infarction without altering von Willebrand factor multimer sizeJeffrey I Zwicker, Flora Peyvandi, Roberta Palla, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 10, 2025
Orthopaedic Surgery Outcomes in Patients With Haemophilia A or B Treated With Extended Half-Life Recombinant Factor VIII and IX Fc Fusion Proteins: A Multicentre Prospective StudyLuigi Piero Solimeno, Roberta Gualtierotti, Emanuele Guido, et al.
Thrombosis and Haemostasis|August 15, 2015
The D173G mutation in ADAMTS-13 causes a severe form of congenital thrombotic thrombocytopenic purpura. A clinical, biochemical and in silico studyStefano Lancellotti, Flora Peyvandi, Maria Teresa Pagliari, et al.
La Radiologia Medica|January 20, 2021
Deep vein thrombosis in COVID-19 patients in general wards: prevalence and association with clinical and laboratory variablesAnna Maria Ierardi, Nicola Gaibazzi, Domenico Tuttolomondo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 17, 2019
Procoagulant imbalance influences cardiovascular and liver damage in chronic hepatitis C independently of steatosisGiordano Sigon, Roberta D'Ambrosio, Mariagrazia Clerici, et al.
Pageof 62

Showing results (411-420 of 611) with videos related to

Sort By:
Pageof 62
Journal of Thrombosis and Haemostasis : JTH|August 22, 2024
Gene therapy for people with hemophilia B: a proposed care delivery model in ItalyGiancarlo Castaman, Giovanni Di Minno, Paolo Simioni, et al.
Research and Practice in Thrombosis and Haemostasis|June 3, 2026
Real-world provider experiences with hemophilia A gene therapy: administration of valoctocogene roxaparvovecFlora Peyvandi, Robert Klamroth, Johannes Oldenburg, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2025
Post hoc analysis of bleeding episodes and clinically relevant pharmacokinetic parameters among children <12 years old with severe hemophilia A receiving once-weekly efanesoctocog alfa prophylaxis in the XTEND-Kids phase 3 multinational trialLynn Malec, Mary Mathias, Amy L Dunn, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 19, 2022
Real-world data on emicizumab prophylaxis in the Milan cohortSara Arcudi, Roberta Gualtierotti, Sonia Marino, et al.
The American Journal of Gastroenterology|July 4, 2020
Acute Portal Vein Thrombosis in SARS-CoV-2 Infection: A Case ReportVincenzo La Mura, Andrea Artoni, Ida Martinelli, et al.
Blood|May 11, 2006
The thrombospondin-1 N700S polymorphism is associated with early myocardial infarction without altering von Willebrand factor multimer sizeJeffrey I Zwicker, Flora Peyvandi, Roberta Palla, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 10, 2025
Orthopaedic Surgery Outcomes in Patients With Haemophilia A or B Treated With Extended Half-Life Recombinant Factor VIII and IX Fc Fusion Proteins: A Multicentre Prospective StudyLuigi Piero Solimeno, Roberta Gualtierotti, Emanuele Guido, et al.
Thrombosis and Haemostasis|August 15, 2015
The D173G mutation in ADAMTS-13 causes a severe form of congenital thrombotic thrombocytopenic purpura. A clinical, biochemical and in silico studyStefano Lancellotti, Flora Peyvandi, Maria Teresa Pagliari, et al.
La Radiologia Medica|January 20, 2021
Deep vein thrombosis in COVID-19 patients in general wards: prevalence and association with clinical and laboratory variablesAnna Maria Ierardi, Nicola Gaibazzi, Domenico Tuttolomondo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 17, 2019
Procoagulant imbalance influences cardiovascular and liver damage in chronic hepatitis C independently of steatosisGiordano Sigon, Roberta D'Ambrosio, Mariagrazia Clerici, et al.
Pageof 62